PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
16.78%
Revenue growth 50-75% of CRWV's 23.55%. Martin Whitman would scrutinize if slower growth is temporary.
72.73%
Cost growth above 1.5x CRWV's 19.16%. Michael Burry would check for structural cost disadvantages.
14.54%
Gross profit growth 50-75% of CRWV's 25.15%. Martin Whitman would scrutinize competitive position.
-1.91%
Margin decline while CRWV shows 1.30% expansion. Joel Greenblatt would examine competitive position.
12.27%
R&D change of 12.27% while CRWV maintains spending. Bruce Berkowitz would investigate effectiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
10.88%
Operating expenses growth 50-75% of CRWV's 17.97%. Bruce Berkowitz would examine efficiency.
14.79%
Similar total costs growth to CRWV's 18.28%. Walter Schloss would investigate norms.
No Data
No Data available this quarter, please select a different quarter.
-11.11%
D&A reduction while CRWV shows 26.15% growth. Joel Greenblatt would examine efficiency.
15.13%
EBITDA growth below 50% of CRWV's 33.05%. Michael Burry would check for structural issues.
-2.20%
EBITDA margin decline while CRWV shows 7.69% growth. Joel Greenblatt would examine position.
19.84%
Operating income growth below 50% of CRWV's 169.93%. Michael Burry would check for structural issues.
2.63%
Operating margin growth below 50% of CRWV's 156.60%. Michael Burry would check for structural issues.
37.21%
Other expenses growth while CRWV reduces costs. John Neff would investigate differences.
20.63%
Pre-tax income growth exceeding 1.5x CRWV's 9.63%. David Dodd would verify competitive advantages.
3.30%
Pre-tax margin growth below 50% of CRWV's 26.86%. Michael Burry would check for structural issues.
20.54%
Tax expense growth above 1.5x CRWV's 3.78%. Michael Burry would check for concerning trends.
20.68%
Net income growth exceeding 1.5x CRWV's 7.67%. David Dodd would verify competitive advantages.
3.35%
Net margin growth below 50% of CRWV's 25.27%. Michael Burry would check for structural issues.
15.38%
EPS growth 50-75% of CRWV's 23.08%. Martin Whitman would scrutinize operations.
25.00%
Similar diluted EPS growth to CRWV's 23.08%. Walter Schloss would investigate industry trends.
4.45%
Share count reduction exceeding 1.5x CRWV's 20.32%. David Dodd would verify capital allocation.
-3.58%
Diluted share reduction while CRWV shows 20.32% change. Joel Greenblatt would examine strategy.